Thomas E. Denion

Array ( [id] => 903611 [patent_doc_number] => 07335724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 11/059775 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3510 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335724.pdf [firstpage_image] =>[orig_patent_app_number] => 11059775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630295 [patent_doc_number] => 07132255 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Identification of compounds that bind biliary glycoprotein and affect cytotoxic T lymphocyte activity' [patent_app_type] => utility [patent_app_number] => 11/049270 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 13070 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132255.pdf [firstpage_image] =>[orig_patent_app_number] => 11049270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951776 [patent_doc_number] => 20050226870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Methods for the treatment of inflammatory joint disease' [patent_app_type] => utility [patent_app_number] => 11/029017 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13927 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226870.pdf [firstpage_image] =>[orig_patent_app_number] => 11029017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074738 [patent_doc_number] => 20050148006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Human GDP-mannose 4,6 dehydratase' [patent_app_type] => utility [patent_app_number] => 11/012286 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3975 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148006.pdf [firstpage_image] =>[orig_patent_app_number] => 11012286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899786 [patent_doc_number] => 20080119400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Modified truncated complement system regulators' [patent_app_type] => utility [patent_app_number] => 10/997454 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11952 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119400.pdf [firstpage_image] =>[orig_patent_app_number] => 10997454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820370 [patent_doc_number] => 20060024683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substances' [patent_app_type] => utility [patent_app_number] => 10/983120 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22982 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024683.pdf [firstpage_image] =>[orig_patent_app_number] => 10983120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803424 [patent_doc_number] => 07423128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => 'Anti-properdin antibodies, and methods for making and using same' [patent_app_type] => utility [patent_app_number] => 10/981300 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22610 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423128.pdf [firstpage_image] =>[orig_patent_app_number] => 10981300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590930 [patent_doc_number] => 20060040382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Tagged epitope protein transposable element' [patent_app_type] => utility [patent_app_number] => 10/968629 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19188 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040382.pdf [firstpage_image] =>[orig_patent_app_number] => 10968629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957938 [patent_doc_number] => 20050214308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Treatment of complement-associated disorders' [patent_app_type] => utility [patent_app_number] => 10/964263 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 35853 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10964263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111166 [patent_doc_number] => 20050208621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => '28 human secreted proteins' [patent_app_type] => utility [patent_app_number] => 10/951993 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 201130 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208621.pdf [firstpage_image] =>[orig_patent_app_number] => 10951993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252432 [patent_doc_number] => 20050074853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Recombinant MHC molecules useful for manipulation of antigen-specific T-cells' [patent_app_type] => utility [patent_app_number] => 10/941152 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19625 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074853.pdf [firstpage_image] =>[orig_patent_app_number] => 10941152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082685 [patent_doc_number] => 20050048065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Methods and compositions containing antigens having a targeting moiety specific for antigen presenting cells for intranasal immunization' [patent_app_type] => utility [patent_app_number] => 10/937403 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7735 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048065.pdf [firstpage_image] =>[orig_patent_app_number] => 10937403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034190 [patent_doc_number] => 20050032700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Adipocyte complement related protein zacrp12' [patent_app_type] => utility [patent_app_number] => 10/912899 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47896 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032700.pdf [firstpage_image] =>[orig_patent_app_number] => 10912899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798004 [patent_doc_number] => 07427591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Suppression of immune response via inhibition of cathepsin S' [patent_app_type] => utility [patent_app_number] => 10/913045 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12493 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427591.pdf [firstpage_image] =>[orig_patent_app_number] => 10913045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127400 [patent_doc_number] => 20050059144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'MHC class II antigen-presenting systems and methods for activating CD4+ T cells' [patent_app_type] => utility [patent_app_number] => 10/903213 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25410 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059144.pdf [firstpage_image] =>[orig_patent_app_number] => 10903213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061070 [patent_doc_number] => 20050003431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/895543 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29558 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003431.pdf [firstpage_image] =>[orig_patent_app_number] => 10895543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7261470 [patent_doc_number] => 20040241180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Notch' [patent_app_type] => new [patent_app_number] => 10/877563 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 6629 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241180.pdf [firstpage_image] =>[orig_patent_app_number] => 10877563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275662 [patent_doc_number] => 20040235113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => '18 human secreted proteins' [patent_app_type] => new [patent_app_number] => 10/874484 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 146424 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235113.pdf [firstpage_image] =>[orig_patent_app_number] => 10874484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033619 [patent_doc_number] => 20050032128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Anti-glycated CD59 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/870342 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23281 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032128.pdf [firstpage_image] =>[orig_patent_app_number] => 10870342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275070 [patent_doc_number] => 20040234521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Polyclonal populations of bispecific molecules and methods of production and uses thereof' [patent_app_type] => new [patent_app_number] => 10/472051 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17915 [patent_no_of_claims] => 112 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234521.pdf [firstpage_image] =>[orig_patent_app_number] => 10472051 [rel_patent_id] =>[rel_patent_doc_number] =>)